NASDAQ: NSPRInspiremd Inc Stock Ownership - Who owns Inspiremd?
Insider buying vs selling
Have Inspiremd Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael Berman | Director | 2024-06-24 | 61,249 | $1.38 | $84.71kBuy |
| Paul Stuka | Director | 2024-06-05 | 87,500 | $1.38 | $121.01kBuy |
| Thomas J. Kester | Director | 2024-05-28 | 30,625 | $1.38 | $42.35kBuy |
| Gary S. Roubin | Director | 2024-05-28 | 30,625 | $1.38 | $42.35kBuy |
NSPR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NSPR insiders and whales buy or sell their stock.
NSPR Shareholders
What type of owners hold Inspiremd Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ofir Paz | 34.57% | 10,263,752 | $25.18M | Insider |
| Rosalind Advisors Inc | 8.41% | 2,495,783 | $6.12M | Institution |
| Marvin Slosman | 8.12% | 2,410,536 | $5.91M | Insider |
| James J. Barry | 7.30% | 2,166,382 | $5.31M | Insider |
| Orbimed Advisors LLC | 7.19% | 2,133,405 | $5.23M | Institution |
| Asher Holzer | 6.48% | 1,925,110 | $4.72M | Insider |
| Marshall Wace LLP | 6.27% | 1,860,405 | $4.56M | Institution |
| Nantahala Capital Management LLC | 5.64% | 1,674,565 | $4.11M | Institution |
| Soleus Capital Management LP | 4.64% | 1,378,128 | $3.38M | Institution |
| Sol J. Barer | 4.42% | 1,311,690 | $3.22M | Insider |
NSPR vs Medical Device Stocks
Inspiremd Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.